Switching From Originator to Biosimilar Human Growth Hormone Using Dialogue Teamwork: Single-Center Experience From Sweden

Biologics in Therapy
doi 10.1007/s13554-013-0011-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Response To: ‘Mandatory, Cost-Driven Switching From Originator Etanercept to Its Biosimilar SB4: Possible Fallout on Non-Medical Switching’ by Cantini and Benucci

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2018English

A Real Concern or Just a Hype? – Evidence on Negative Clinical Consequences of Switching From Originator to Biosimilar Based on a Systematic Literature Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

CPC-003 a Retrospective Analysis of the Switches From Originator and Biosimilar Recombinant Human Erythropoietins in Chronic Kidney Disease

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Hot Flushes, Hormone Therapy and Alternative Treatments: 30 Years of Experience From Sweden

Climacteric
MedicineGynecologyObstetrics
2014English

Switching to Omnitrope® From Other Recombinant Human Growth Hormone Therapies: A Retrospective Study in an Integrated Healthcare System

Biologics in Therapy
2014English

How Safe Is Conversion From Tacrolimus to Its Generic Drug?—A Single Center Experience

Open Journal of Nephrology
2012English

Clinicopathological Features of Myeloid Sarcoma Patients From a Single Center Experience

TURKISH MEDICAL STUDENT JOURNAL
2020English

Switching From Originator Biological Agents to Biosimilars: What Is the Evidence and What Are the Issues?

RMD Open
RheumatologyAllergyImmunology
2017English

Predicting Bull Growth Performance and Carcass Composition From Growth Hormone Response to Growth Hormone-Releasing Hormone.

Journal of Animal Science
Animal ScienceZoologyGeneticsMedicineFood Science
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy